GlassScriptPhysician profile
Hector Velez-Camacho
NPI 1104069897
$8,763.71
in general payments reported to CMS, 2019-2025
47 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,505 · 2020: $965 · 2021: $1,043 · 2022: $710 · 2023: $585 · 2024: $1,168 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,520.46 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,235.17 | 2019-2025 | Ubrelvy, Qulipta |
| Amgen INC. | $1,207.32 | 2019-2025 | Uplizna, Aimovig |
| Ucb, INC. | $930.01 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Pfizer INC. | $465.86 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $393.80 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $377.00 | 2019-2020 | |
| Sk Life Science, INC. | $370.38 | 2021-2025 | Xcopri |
| Sunovion Pharmaceuticals INC. | $350.47 | 2019-2021 | |
| Eisai INC. | $326.24 | 2019-2024 | |
| Lilly USA, LLC | $277.73 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Allergan, INC. | $277.68 | 2019-2022 | |
| Adamas Pharmaceuticals, INC. | $255.95 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.75 | 2021-2025 | Hyqvia |
| Biohaven Pharmaceutical Holding Company LTD. | $152.60 | 2022 | |
| Genzyme Corporation | $139.29 | 2019 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Velez-Camacho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.